261 related articles for article (PubMed ID: 36412324)
1. Consensus guidelines on management of oral potentially malignant disorders.
Birur PN; Patrick S; Warnakulasuriya S; Gurushanth K; Raghavan SA; Rath GK; Chaturvedi P; Chandru V; Mathew B; Prabhash K; Gurudath S; Mukhia N; Sunny SP; Mehrotra R; Vivek V; Patil S; Kumar GS; Fasalkar S; Pratima R; Kuriakose MA
Indian J Cancer; 2022; 59(3):442-453. PubMed ID: 36412324
[TBL] [Abstract][Full Text] [Related]
2. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma.
Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407
[TBL] [Abstract][Full Text] [Related]
3. American Association of Oral and Maxillofacial Surgeon's Position Paper on Oral Mucosal Dysplasia.
Carlson ER; Kademani D; Ward BB; Oreadi D
J Oral Maxillofac Surg; 2023 Aug; 81(8):1042-1054. PubMed ID: 37244288
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and Management of Oral Potentially Malignant Disorders.
Nadeau C; Kerr AR
Dent Clin North Am; 2018 Jan; 62(1):1-27. PubMed ID: 29126487
[TBL] [Abstract][Full Text] [Related]
6. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer.
Warnakulasuriya S; Kujan O; Aguirre-Urizar JM; Bagan JV; González-Moles MÁ; Kerr AR; Lodi G; Mello FW; Monteiro L; Ogden GR; Sloan P; Johnson NW
Oral Dis; 2021 Nov; 27(8):1862-1880. PubMed ID: 33128420
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and factors associated with oral potentially malignant disorders and oral squamous cell carcinoma: An institutional study.
Shah JS; Dubey J
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S536-S544. PubMed ID: 38384016
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
[TBL] [Abstract][Full Text] [Related]
9. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management.
Warnakulasuriya S
Oral Oncol; 2020 Mar; 102():104550. PubMed ID: 31981993
[TBL] [Abstract][Full Text] [Related]
10. ICI-based therapies: A new strategy for oral potentially malignant disorders.
Wang T; Sun S; Zeng X; Li J
Oral Oncol; 2023 May; 140():106388. PubMed ID: 37054586
[TBL] [Abstract][Full Text] [Related]
11. Developmental synergism in the management of oral potentially malignant disorders.
Tan YQ; Li ZT; Zhou G
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103563. PubMed ID: 37031901
[TBL] [Abstract][Full Text] [Related]
12. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
[TBL] [Abstract][Full Text] [Related]
13. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
14. [Update on current care guidelines: oral cancer].
Duodecim; 2012; 128(7):770-1. PubMed ID: 22612027
[TBL] [Abstract][Full Text] [Related]
15. Dentists' Perception of Oral Potentially Malignant Disorders.
Tarakji B
Int Dent J; 2022 Jun; 72(3):414-419. PubMed ID: 35227496
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the evidence of photodynamic therapy for oral potentially malignant disorders and oral squamous cell carcinoma: An overview of systematic reviews.
Schuch LF; Schmidt TR; Kirschnick LB; de Arruda JAA; Campagnol D; Martins MAT; Santos-Silva AR; Lopes MA; Vargas PA; Bagnato VS; Kurachi C; Guerra ENS; Martins MD
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103531. PubMed ID: 36963644
[TBL] [Abstract][Full Text] [Related]
17. History and future perspectives for the use of fluorescence visualization to detect oral squamous cell carcinoma and oral potentially malignant disorders.
Tomo S; Miyahara GI; Simonato LE
Photodiagnosis Photodyn Ther; 2019 Dec; 28():308-317. PubMed ID: 31600576
[TBL] [Abstract][Full Text] [Related]
18. [Current concepts in diagnosis and treatment of oral malignant tumors].
Hullmann MM; Reichert TE
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Sep; 54(9):1083-8. PubMed ID: 21887623
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review.
Yap T; Pruthi N; Seers C; Belobrov S; McCullough M; Celentano A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054041
[TBL] [Abstract][Full Text] [Related]
20. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
